Literature DB >> 26589554

The relationships of irisin with bone mineral density and body composition in PCOS patients.

Shanshan Gao1,2, Yan Cheng3, Lingling Zhao3, Yuxin Chen1,2, Yu Liu3.   

Abstract

OBJECTIVE: Our study aims to assay the irisin level and investigate the relationships of irisin level with body mass index (BMI), body composition and bone metabolism in the polycystic ovary syndrome (PCOS) and control women.
METHODS: Fifty two PCOS and 39 control women were recruited. Serum sex hormone, fasting insulin and C-peptide were tested. Fasting serum irisin and adiponectin were measured with enzyme-linked immunosorbent assay. Body composition and bone mineral density were assayed by dual energy X-ray absorptiometry.
RESULTS: Polycystic ovary syndrome women showed different body compositions compared with controls. Serum irisin level of PCOS did not show significant difference compared with controls although it was decreased. The level of adiponectin in PCOS patients was significantly reduced. BMI had no correlation with irisin level. It indicated a positive correlation between serum irisin levels and bone mineral density in the control group and a negative correlation in the PCOS group after BMI and age adjusted. Furthermore, total lean mass has a significant effect on irisin concentration in the PCOS group. There are no correlations between adiponection and body compositions and bone mineral density in both groups.
CONCLUSIONS: The abnormal body composition in PCOS may contribute to the circulation irisin. The crosstalk of irisin in different organs was found and may be related to disease development in PCOS.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adiponectin; body composition; bone metabolism; irisin; polycystic ovary syndrome

Mesh:

Substances:

Year:  2016        PMID: 26589554     DOI: 10.1002/dmrr.2767

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

Review 1.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

2.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 3.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

4.  Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy.

Authors:  Fatin Shallal Farhan; Shatha Sami Hussien
Journal:  J Obstet Gynaecol India       Date:  2018-09-15

5.  Predicting the risk of sarcopenia in elderly patients with patellar fracture: development and assessment of a new predictive nomogram.

Authors:  Yi-Sheng Chen; Yan-Xian Cai; Xue-Ran Kang; Zi-Hui Zhou; Xin Qi; Chen-Ting Ying; Yun-Peng Zhang; Jie Tao
Journal:  PeerJ       Date:  2020-04-15       Impact factor: 2.984

6.  Irisin deletion induces a decrease in growth and fertility in mice.

Authors:  Yunyao Luo; Xiaoyong Qiao; Yaxian Ma; Hongxia Deng; Charles C Xu; Liangzhi Xu
Journal:  Reprod Biol Endocrinol       Date:  2021-02-13       Impact factor: 5.211

7.  The Effects of 8-Week Resistance and Endurance Trainings on Bone Strength Compared to Irisin Injection Protocol in Mice.

Authors:  Shirin Shahabi; Fahimeh Esfarjani; Jalil Reisi; Sedigheh Momenzadeh; Mohammad-Saeid Jami; Saeed Zamani
Journal:  Adv Biomed Res       Date:  2021-11-26

8.  The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome.

Authors:  Samira Behboudi-Gandevani; Mehdi Hedayati; Mohammad Ali Mansournia; Maryam Nazemipour; Maryam Rahmati; Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2021-05-31

Review 9.  Irisin: circulating levels in serum and its relation to gonadal axis.

Authors:  Yunyao Luo; Xiaoyong Qiao; Liangzhi Xu; Guoning Huang
Journal:  Endocrine       Date:  2022-01-17       Impact factor: 3.633

10.  Serum Irisin Levels and its Association with Blood Glucose and Insulin Indices in Diagnosing Insulin Resistance in Adolescents with Polycystic Ovarian Syndrome.

Authors:  Bhawina Sharan; Haritha Sagili; Sadish Kumar Kamalanathan; Subitha Lakshminarayanan
Journal:  J Hum Reprod Sci       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.